The primary antibodies used in this study were IG2BP2 (11601–1-AP; ProteinTech Group, Inc), Phospho-Akt (Ser473) (#4060, CST), GAPDH (#5174, CST), Akt (#4691, CST), cleaved PARP (#5625, CST), cleaved caspase-3 (#9664, CST), CDK2 (#2546, CST), p21 Waf1/Cip1 (#2947, CST) and Cyclin D1 (#2978, CST). The secondary antibodies and enhanced chemiluminescence reagent were purchased from Boster (Wuhan, China). The protein extraction and western blot analysis were performed as described in our previous study [5 (link)].
Free full text: Click here